TipRanks
Advertisement
Advertisement

KYNB Stock Latest News

FibroGen Inc trading resumes
The FlyFibroGen Inc trading resumes
5d ago
KYNB
FibroGen Inc trading halted, volatility trading pause
PremiumThe Fly
FibroGen Inc trading halted, volatility trading pause
5d ago
KYNB
Kyntra Bio Streamlines Financing, Strengthens Balance Sheet
PremiumCompany Announcements
Kyntra Bio Streamlines Financing, Strengthens Balance Sheet
15d ago
8K
KYNB
Kyntra Bio cuts max royalty cap to $65M from $125M, pays $42.6M upfront
PremiumThe Fly
Kyntra Bio cuts max royalty cap to $65M from $125M, pays $42.6M upfront
15d ago
KYNB
Kyntra Bio Earnings Call Highlights CD46 Oncology Push
PremiumCompany Announcements
Kyntra Bio Earnings Call Highlights CD46 Oncology Push
22d ago
KYNB
Kyntra Earns Buy Rating on Strong Cash Runway and Multiple Late-Stage Clinical Catalysts
PremiumRatingsKyntra Earns Buy Rating on Strong Cash Runway and Multiple Late-Stage Clinical Catalysts
29d ago
KYNB
Kyntra Bio reports Q2 EPS $2.96, consensus ($3.18)
Premium
The Fly
Kyntra Bio reports Q2 EPS $2.96, consensus ($3.18)
1M ago
KYNB
Kyntra Bio Confronts Nasdaq Listing Risk as Asset and Revenue Shortfall Threatens Global Select Status
Premium
Company Announcements
Kyntra Bio Confronts Nasdaq Listing Risk as Asset and Revenue Shortfall Threatens Global Select Status
1M ago
KYNB
KYNB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
KYNB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
KYNB
Kyntra Bio initiated with an Outperform at Oppenheimer
PremiumThe Fly
Kyntra Bio initiated with an Outperform at Oppenheimer
2M ago
KYNB
Kyntra Bio Shareholders Back Board, Pay and Auditor
PremiumCompany Announcements
Kyntra Bio Shareholders Back Board, Pay and Auditor
3M ago
8K
KYNB
Kyntra Bio to present additional MATTERHORN trial data at EHA
PremiumThe Fly
Kyntra Bio to present additional MATTERHORN trial data at EHA
3M ago
KYNB
Kyntra Bio Receives Final Payment for China Divestiture
PremiumCompany AnnouncementsKyntra Bio Receives Final Payment for China Divestiture
3M ago
8K
KYNB
Kyntra Bio initiated with a Buy at Rodman & Renshaw
Premium
The Fly
Kyntra Bio initiated with a Buy at Rodman & Renshaw
3M ago
KYNB
Kyntra Bio Warned of Nasdaq Non‑Compliance, Faces Delisting Risk Without Remediation Plan by May 18, 2026
Premium
Company Announcements
Kyntra Bio Warned of Nasdaq Non‑Compliance, Faces Delisting Risk Without Remediation Plan by May 18, 2026
4M ago
KYNB
FibroGen Earnings Call Highlights Clinical Momentum, Runway
PremiumCompany Announcements
FibroGen Earnings Call Highlights Clinical Momentum, Runway
4M ago
KYNB
Kyntra: Advancing Oncology and LR-MDS Programs with Strong Cash Position; Buy Rating and $43 Price Target Reiterated
PremiumRatings
Kyntra: Advancing Oncology and LR-MDS Programs with Strong Cash Position; Buy Rating and $43 Price Target Reiterated
4M ago
KYNB
FGEN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
FGEN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
KYNB
Kyntra Bio Faces Nasdaq Compliance Challenge After Revenue Shift
PremiumCompany Announcements
Kyntra Bio Faces Nasdaq Compliance Challenge After Revenue Shift
5M ago
8K
KYNB
FibroGen Earnings Call: Cash-Rich, Data-Heavy, Unproven
PremiumCompany AnnouncementsFibroGen Earnings Call: Cash-Rich, Data-Heavy, Unproven
6M ago
KYNB
Advancing Pipeline and 2026 Clinical Catalysts Underpin Buy Rating on Kyntra Bio
Premium
Ratings
Advancing Pipeline and 2026 Clinical Catalysts Underpin Buy Rating on Kyntra Bio
6M ago
KYNB
Maintaining a Hold on Kyntra Bio Amid Pipeline Refocus and Pending Clinical Inflection Points
Premium
Ratings
Maintaining a Hold on Kyntra Bio Amid Pipeline Refocus and Pending Clinical Inflection Points
6M ago
KYNB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >